文献速递细菌感染、耐药与抗菌药物

抗生素联合用药的半机制PKPD模型:方法、应用与意义

Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations.
PubMed 文献 · Clin Microbiol Infect · 2017-12-08

模型模拟常用于比较单药与联合方案或提出优化方案,支持联合给药方案制定与耐药抑制。

要点

  • 半机制PKPD模型可整合联合用药的PK与PD知识,处理群体变异与参数不确定性。
  • 模型模拟常用于比较单药与联合方案,或提出优化联合给药方案。

核心结论

  • 半机制PKPD模型有助于高效开发优化杀菌和/或抑制耐药的抗生素联合给药方案。

主要发现

  • 文献报告了多种相互作用函数,用于描述联合药物效应并表征PKPD模型下偏离加性的情况。
  • 模型模拟常用于比较单药与联合给药方案和/或提出改进的给药方案。

临床怎么用

  • 基于体外单药与联合实验构建半机制PKPD模型,可整合PK/PD特征与群体变异及参数不确定性,辅助联合方案决策。

局限性

  • 传统PKPD指数方法无法直接用于联合用药,且探索所有剂量组合不可行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deriving suitable dosing regimens for antibiotic combination therapy poses several challenges as the drug interaction can be highly complex, the traditional pharmacokinetic-pharmacodynamic (PKPD) index methodology cannot be applied straightforwardly, and exploring all possible dose combinations is unfeasible. Therefore, semi-mechanistic PKPD models developed based on in vitro single and combination experiments can be valuable to suggest suitable combination dosing regimens. AIMS: To outline how the interaction between two antibiotics has been characterized in semi-mechanistic PKPD models. We also explain how such models can be applied to support dosing regimens and design future studies. SOURCES: PubMed search for published semi-mechanistic PKPD models of antibiotic drug combinations. CONTENT: Thirteen publications were identified where ten had applied subpopulation synergy to characterize the combined effect, i.e. independent killing rates for each drug and bacterial subpopulation. We report the various types of interaction functions that have been used to describe the combined drug effects and that characterized potential deviations from additivity under the PKPD model. Simulations from the models had commonly been performed to compare single versus combined dosing regimens and/or to propose improved dosing regimens. IMPLICATIONS: Semi-mechanistic PKPD models allow for integration of knowledge on the interaction between antibiotics for various PK and PD profiles, and can account for associated variability within the population as well as parameter uncertainty. Decisions on suitable combination regimens can thereby be facilitated. We find the application of semi-mechanistic PKPD models to be essential for efficient development of antibiotic combination regimens that optimize bacterial killing and/or suppress resistance development.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Brill MJE, Kristoffersson AN, Zhao C, et al. Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations. Clin Microbiol Infect. 2017. PMID: 29229429. doi:10.1016/j.cmi.2017.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。